Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Malignant Tumor Treatment Technologies Logo
Malignant Tumor Treatment Technologies Growth Score
85
CB Rank
686026
Heat Score
62
Malignant Tumor Treatment Technologies is a medical firm that develops Levutricin, which promotes reoxidation and fixes damaged DNA.
Founded
obfuscation
PrivateSeed Tokyo, Tokyo, Japan51-100 www.mt3.co.jp
Health Care
Manufacturing
Medical
Pet
Pharmaceutical
Overview

Malignant Tumor Treatment Technologies
Growth Score
85
Heat Score
62

Growth Score85
-1 pts
in past quarter
Heat Score 62
3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Malignant Tumor Treatment Technologies

CB Rank
686026
Malignant Tumor Treatment Technologies is a medical firm that develops Levutricin, which promotes reoxidation and fixes damaged DNA.
Founded
obfuscation
PrivateSeed Tokyo, Tokyo, Japan51-100 www.mt3.co.jp
Health Care
Manufacturing
Medical
Pet
Pharmaceutical

Funding Rounds

Seed
OBF
in
obfuscation

Details

Legal Name Malignant Tumor Treatment Technologies, Inc.
Also Known As エム・ティー・スリー, MT3
Operating Status Active
Company Type For Profit
About the Company
MT3 is a developer of radiosensitizer technology designed to offer treatment to animals suffering from tumors. They provide therapeutic agents, treat forms of tumors, and offer anti tumor treatment.
Contact Email info@mt3.co.jp
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Levutricin
Levutricin is a radiosensitizer drug designed to enhance the effectiveness of radiation therapy by promoting reoxidation and repairing damaged DNA.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Malignant Tumor Treatment Technologies Logo
Seed Round - Malignant Tumor Treatment Technologies
2
obfuscation
— Seed
obfuscation
Seed Round - Malignant Tumor Treatment Technologies Logo
Seed Round - Malignant Tumor Treatment Technologies
2
obfuscation
— Seed
obfuscation
Seed Round - Malignant Tumor Treatment Technologies Logo
Seed Round - Malignant Tumor Treatment Technologies
2
obfuscation
— Seed
obfuscation
Seed Round - Malignant Tumor Treatment Technologies Logo
Seed Round - Malignant Tumor Treatment Technologies
2
obfuscation
— Seed
obfuscation
Seed Round - Malignant Tumor Treatment Technologies Logo
Seed Round - Malignant Tumor Treatment Technologies
2
obfuscation
— Seed

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Malignant Tumor Treatment Technologies Logo
Seed Round - Malignant Tumor Treatment Technologies
2
obfuscation
— Seed
obfuscation
Seed Round - Malignant Tumor Treatment Technologies Logo
Seed Round - Malignant Tumor Treatment Technologies
2
obfuscation
— Seed
obfuscation
Seed Round - Malignant Tumor Treatment Technologies Logo
Seed Round - Malignant Tumor Treatment Technologies
2
obfuscation
— Seed
obfuscation
Seed Round - Malignant Tumor Treatment Technologies Logo
Seed Round - Malignant Tumor Treatment Technologies
2
obfuscation
— Seed
obfuscation
Seed Round - Malignant Tumor Treatment Technologies Logo
Seed Round - Malignant Tumor Treatment Technologies
2
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100
News

News and Press

News•Jul 12, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Interest Signals

TopicSurge Score
Image Editing Software Logo
Image Editing Software
85
Proof of Play Logo
Proof of Play
78
Image Analysis Logo
Image Analysis
75

Active Website Tech Count

25Malignant Tumor Treatment Technologies is actively using 25 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.

Total IP

4The intellectual property of Malignant Tumor Treatment Technologies includes 4 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Malignant Tumor Treatment Technologies's headquarters? Malignant Tumor Treatment Technologies is located in Tokyo, Tokyo, Japan.Who invested in Malignant Tumor Treatment Technologies? Malignant Tumor Treatment Technologies has 2 investors including REVIC and  Gungin Consulting.When was the last funding round for Malignant Tumor Treatment Technologies? Malignant Tumor Treatment Technologies closed its last funding round on
obfuscation
from a Seed round.Who are Malignant Tumor Treatment Technologies's competitors? Alternatives and possible competitors to Malignant Tumor Treatment Technologies may include Nuvectis Pharma, Whitehawk Therapeutics, and  Lunit.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6ec160d 1)
|